Scarica l'app Stockscreener
17.50
1.35%
-0.24
Precedente Chiudi:
$17.74
Aprire:
$17.56
Volume 24 ore:
323.58K
Relative Volume:
6.03
Capitalizzazione di mercato:
$825.55M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.68%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$16.50
$18.43
Intervallo di 1 settimana:
$16.50
$18.43
Portata 52W:
$16.41
$18.43
Odyssey Therapeutics Inc Stock (ODTX) Company Profile
Nome
Odyssey Therapeutics Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare ODTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ODTX
Odyssey Therapeutics Inc
|
17.50 | 836.87M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Odyssey Therapeutics Inc Borsa (ODTX) Ultime notizie
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Odyssey Therapeutics hits $900M valuation in Nasdaq debut, stock climbs 13% before diving lower - MSN
IPO Tracker 2026: Parabilis follows hefty Regeneron deal with IPO push - BioSpace
Odyssey Therapeutics (ODTX) Stock Analysis Report | Financials & Insights - Benzinga
Simeon George Discloses Investment at Odyssey Therapeutics with 8.0% Stake - TradingView
SR One funds disclose 8% Odyssey Therapeutics (ODTX) stake after IPO - Stock Titan
TPG funds take 7.8% Odyssey Therapeutics (ODTX) stake via $25M share purchase - Stock Titan
Odyssey Therapeutics (ODTX) 10K Form and Latest SEC Filings 2026 - MarketBeat
Odyssey Therapeutics (ODTX) Stock Chart and Price History 2026 - MarketBeat
Dimension Management Discloses Investment at Odyssey Therapeutics with 7.1% Stake - TradingView
Jeito II S.L.P. Discloses Investment in Odyssey Therapeutics with 7.8% Stake - TradingView
What is the current Price Target and Forecast for Odyssey Therapeutics, Inc. (ODTX) - Zacks Investment Research
Immunology drug developer Odyssey seeks US IPO again - MSN
Immune system biotech odyssey seeks $238.3 million in US IPO - MSN
ODTX Stock Chart | ODYSSEY THERAPEUTICS INC (NASDAQ:ODTX) - ChartMill
Odyssey Therapeutics Prices $304 Million Upsized IPO and Concurrent Private Placement - Global Legal Chronicle
Odyssey Therapeutics (ODTX) Stock Trends and Sentiment 2026 - MarketBeat
ODTX Price History for Odyssey Therapeutics Stock - Barchart.com
ODYSSEY THERAPEUTICS INC (ODTX) - Minichart
Major Investor Quietly Makes a Massive New Bet on Odyssey Therapeutics - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
ODTX | Odyssey Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Major Insider Move Signals Growing Confidence in Odyssey Therapeutics - TipRanks
ODTX News Today | Why did Odyssey Therapeutics stock drop today? - MarketBeat
Total assets of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Statistics – NASDAQ:ODTX - TradingView
ODTX Stock Price, Quote & Chart | ODYSSEY THERAPEUTICS INC (NASDAQ:ODTX) - ChartMill
Odyssey Therapeutics, Inc. Dividends – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Revenue Breakdown – NASDAQ:ODTX - TradingView
Odyssey Therapeutics, Inc. Earnings and Revenue – NASDAQ:ODTX - TradingView
ODYSSEY THERAPEUTICS INC Statistics – BOATS:ODTX - TradingView
Diluted earnings per share (diluted EPS) of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Odyssey Therapeutics Hits $900M Valuation In Nasdaq Debut, Stock Climbs 13% Before Diving Lower - Stocktwits
ODTX Price Today: Odyssey Therapeutics, Inc. Stock Price, Quote & Chart - MEXC Exchange
Basic earnings per share (basic EPS) of ODYSSEY THERAPEUTICS INC – BOATS:ODTX - TradingView
Non-operating income (total) of ODYSSEY THERAPEUTICS INC – BOATS:ODTX - TradingView
Operating income of Odyssey Therapeutics, Inc. – NASDAQ:ODTX - TradingView
Immunology drug developer Odyssey prices upsized IPO - MSN
Odyssey raises $304 million in upsized Nasdaq debut - The Pharma Letter
ODTX | Odyssey Therapeutics, Inc. Common Institutional Ownership - Quiver Quantitative
ODTX: Odyssey Therapeutics, Inc.Price & EPS Surprise - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Gross Margin (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Price - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Gross Profit (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Net Income (Quarterly) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Total Expenses (TTM) - Zacks Investment Research
Dividend HistoryOdyssey Therapeutics, Inc. (ODTX) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Total Long Term Debt (Quarterly) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Earnings Yield (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Revenue (TTM) - Zacks Investment Research
Odyssey Therapeutics, Inc. (ODTX) Enterprise Value - Zacks Investment Research
Odyssey Therapeutics Inc Azioni (ODTX) Dati Finanziari
Non sono disponibili dati finanziari per Odyssey Therapeutics Inc (ODTX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Odyssey Therapeutics Inc Azioni (ODTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Dimension Capital II, L.P. | Director |
May 08 '26 |
Buy |
18.00 |
1,111,111 |
19,999,998 |
3,333,516 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
May 11 '26 |
Buy |
18.00 |
555,555 |
9,999,990 |
1,831,383 |
| SR ONE CAPITAL MANAGEMENT, LLC | 10% Owner |
May 11 '26 |
Sale |
18.00 |
1,780 |
32,040 |
440,981 |
| LEIDEN JEFFREY M | Director |
May 08 '26 |
Buy |
20.00 |
5,000 |
100,000 |
270,198 |
| Haas Jason | Chief Financial Officer |
May 08 '26 |
Buy |
20.00 |
1,000 |
20,000 |
62,908 |
| Li Nan (LN) | Director |
May 11 '26 |
Buy |
18.00 |
1,111,111 |
19,999,998 |
3,333,516 |
| Chu Shelley | Director |
May 11 '26 |
Buy |
18.00 |
11,111 |
199,998 |
11,111 |
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):